Recent research has highlighted the bone-health risks of taking thyroid medication, prescribed to 23 million Americans.

Commonly prescribed thyroid drug levothyroxine was linked with bone mass and bone density loss in a cohort of older adults in a recent study.

The loss of bone mineral density and bone mass is called osteoporosis, a disease that affects an estimated 10 million ...

Levothyroxine, the second-most-commonly prescribed medication for older adults in the U.S., has been linked to lower bone density.

Treatment with levothyroxine may result in bone loss in older euthyroid patients, according to data from a longitudinal ...

Prescribed to treat hypothyroidism and thyroid cancer, around 7% of the U.S. population takes levothyroxine. The drug is a ...

ONE of the most commonly prescribed drugs in the UK, used to treat a hormone condition, may be linked to a bone snapping ...

New research suggests that a thyroid medication often prescribed to older Americans may be linked to a common problem in old ...

Levothyroxine, commercially known as Synthroid among other names, is commonly used to treat an underactive thyroid.

A new study reveals a potential link between levothyroxine, a common treatment for underactive thyroid, and bone loss in ...

Levothyroxine, the second most commonly prescribed medication among older adults in the U.S., may be associated with bone ...

After an average follow-up period of 6.3 years, older adults on levothyroxine had a greater loss of both total body bone mass and bone density.